ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637693 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637693; 2) Community: the network communities that were significantly associated with the response to NSC 637693; 3) Molecule: the relationships between components within communities and NSC 637693; 4) MDR: the compounds that were significantly associated with the NSC 637693.

NSC Compound Enrichment Correlation
NSC 363143 Stannane, dichlorodiphenyl-, compd. with 1,4,7,10,13,16-hexaoxacyclooctadecane (1:1) 0.0462077035966081 0.20047713
NSC 46691 Null 0.0462077035966081 -0.21220426
NSC 607993 Null 0.0462077035966081 -0.05407459
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0462077035966081 0.34597066
NSC 623436 TGF.alpha.-PE40 0.0462077035966081 -0.25691572
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0462077035966081 0.3093808
NSC 631542 Null 0.0462077035966081 0.22673626
NSC 634785 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride 0.0462077035966081 0.37361369
NSC 639187 Landomycin A 0.0462077035966084 0.49796316
NSC 655748 Null 0.0462077035966084 0.39894285
Total:64  Current:60    [First] [Prev] [Next] [Last]